Skip to main content
OpenTrials

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,014 public trials 549 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Active, Not Recruiting

Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

NCT05316701

Conditions
Acute Leukemia, Acute Lymphoid Leukemia, Acute Myeloid Leukemia, +20 more
Locations
  • City of Hope Duarte, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • UC Davis Sacramento, California, United States
  • Stanford Health Care Stanford, California, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT05479994

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +17 more
Locations
  • Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital Hefei, Anhui, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • Beijing Jishuitan Hospital Beijing, Beijing Municipality, China
  • Beijing Hospital Beijing, Beijing Municipality, China
View all 50 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of ALLO-501A Anti-CD19 Allogeneic CAR T Cells in Adults With Relapsed/Refractory Large B Cell Lymphoma, Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (ALPHA2)

NCT04416984

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 29 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period

NCT06524375

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Rocky Mountain Cancer Centers (Aurora) - USOR Aurora, Colorado, United States
  • Cancer Specialists of North Florida Jacksonville, Florida, United States
  • Fort Wayne Medical Oncology and Hematology, Inc Fort Wayne, Indiana, United States
View all 20 locations
View Trial Details

Related conditions